Table 1.
Demographic, Clinical and Histopathological Data of Bladder Cancer Patients
| Control | Cases | P- value | ||
|---|---|---|---|---|
| N=50 | N=150 | |||
| Age | Mean±SD | 44.5±12.4 | 59.4±8.6 | 0.001** |
| Min - Max | 22.0 - 68.0 | 26.0 - 73.0 | ||
| Sex | Female | 17 (34.0%) | 21 (14.0%) | 0.1 |
| Male | 33 (66.0%) | 129 (86.0%) | ||
| Bilhariziasis | Negative | 50 (100.0%) | 33 (22.0%) | 0.001** |
| Positive | 0 (0.0%) | 117 (78.0%) | ||
| Smoker | No | 50 (100.0%) | 39 (26.0%) | 0.001** |
| Yes | 0 (0.0%) | 111 (74.0%) | ||
| Clinical Ex. | Negative | 50 (100.0%) | 0 (0.0%) | N.A |
| T1 | 0 (0.0%) | 21 (14.0%) | ||
| T2 | 0 (0.0%) | 75 (50.0%) | ||
| T3 | 0 (0.0%) | 54 (36.0%) | ||
| Cytology | Negative | 50 (100.0%) | 54 (36.0%) | 0.001** |
| Positive | 0 (0.0%) | 96 (64.0%) | ||
| Histopathological characteristics | Negative | 50 (100.0%) | 0 (0.0%) | N.A |
| Squamous cell carcinoma | 0 (0.0%) | 30 (20.0%) | ||
| Urothelial carcinoma | 0 (0.0%) | 120 (80.0%) | ||
| Stage of Tumor | Negative for malignancy | 50 (100.0%) | 0 (0.0%) | N.A |
| Non muscle invasive bladder cancer(NMIBC) | 0 (0.0%) | 12 (8.0%) | ||
| Muscle invasive bladder cancer(MIBC) | 0 (0.0%) | 123 (82.0%) | ||
| Superficial bladder cancer | 0 (0.0%) | 15 (10.0%) | ||
| Serum creatinine | Normal | 50 (100.0%) | 123 (82.0%) | 0.001** |
| High | 0 (0.0%) | 27 (18.0%) | ||
| Lymph node | Negative for malignancy | 50 (100.0%) | 75 (50.0%) | 0.001** |
| Positive | 0 (0.0%) | 75 (50.0%) | ||
| Gradesof Tumor | Negative | 50 (100.0%) | 0 (0.0%) | N.A |
| GI | 0 (0.0%) | 15 (10.0%) | ||
| GII | 0 (0.0%) | 39 (26.0%) | ||
| GIII | 0 (0.0%) | 96 (64.0%) |
Age is represented as Mean ± SD; the data were analyzed by student t test. While Sex, Bilhariziasis, Smoker, Clinical Ex., Cytology, Histopathological characteristics, Stage of Tumor, Serum creatinine, Lymph node, and Grades of Tumor are represented as F (%) frequency and percent; the data were analyzed by X2 test. * P-value <0.05 is significant, ** P. value <0.01 is highly significant.